Variations and obstacles in the use of coagulation factor concentrates for major trauma bleeding across Europe: outcomes from a European expert meeting

PURPOSE: Trauma is a leading cause of mortality, with major bleeding and trauma-induced coagulopathy (TIC) contributing to negative patient outcomes. Treatments for TIC include tranexamic acid (TXA), fresh frozen plasma (FFP), and coagulation factor concentrates (CFCs, e.g. prothrombin complex conce...

Descripción completa

Detalles Bibliográficos
Autores principales: Černý, Vladimir, Maegele, Marc, Agostini, Vanessa, Fries, Dietmar, Leal-Noval, Santiago R., Nardai, Gábor, Nardi, Giuseppe, Östlund, Anders, Schöchl, Herbert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7782571/
https://www.ncbi.nlm.nih.gov/pubmed/33399876
http://dx.doi.org/10.1007/s00068-020-01563-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7782571/
https://www.ncbi.nlm.nih.gov/pubmed/33399876
http://dx.doi.org/10.1007/s00068-020-01563-2

Ejemplares similares